Drug Shortage Report for QUELICIN
Report ID | 111759 |
Drug Identification Number | 00038172 |
Brand name | QUELICIN |
Common or Proper name | QUELICIN |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | SUCCINYLCHOLINE CHLORIDE |
Strength(s) | 20MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAVENOUS |
Packaging size | 25 x 10mL vial |
ATC code | M03AB |
ATC description | MUSCLE RELAXANTS, PERIPHERALLY ACTING AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2020-05-08 |
Actual start date | |
Estimated end date | |
Actual end date | 2020-05-13 |
Shortage status | Resolved |
Updated date | 2020-05-14 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2020-05-14 | English | Compare |
v5 | 2020-05-13 | French | Compare |
v4 | 2020-05-13 | English | Compare |
v3 | 2020-05-09 | English | Compare |
v2 | 2020-04-09 | French | Compare |
v1 | 2020-04-09 | English | Compare |
Showing 1 to 6 of 6